475 related articles for article (PubMed ID: 16476048)
21. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.
Shu Y; Hu Q; Long H; Chang C; Lu Q; Xiao R
Clin Rev Allergy Immunol; 2017 Apr; 52(2):260-272. PubMed ID: 27687891
[TBL] [Abstract][Full Text] [Related]
23. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
24. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of Foxp3 in regulatory T cells.
Haiqi H; Yong Z; Yi L
Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
[TBL] [Abstract][Full Text] [Related]
26. Effects of natalizumab treatment on Foxp3+ T regulatory cells.
Stenner MP; Waschbisch A; Buck D; Doerck S; Einsele H; Toyka KV; Wiendl H
PLoS One; 2008 Oct; 3(10):e3319. PubMed ID: 18836525
[TBL] [Abstract][Full Text] [Related]
27. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
28. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
29. Forkhead box protein 3: essential immune regulatory role.
Nik Tavakoli N; Hambly BD; Sullivan DR; Bao S
Int J Biochem Cell Biol; 2008; 40(11):2369-73. PubMed ID: 18037337
[TBL] [Abstract][Full Text] [Related]
30. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
Chi LJ; Wang HB; Zhang Y; Wang WZ
J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
[TBL] [Abstract][Full Text] [Related]
31. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.
Mor A; Luboshits G; Planer D; Keren G; George J
Eur Heart J; 2006 Nov; 27(21):2530-7. PubMed ID: 16954132
[TBL] [Abstract][Full Text] [Related]
32. Differentiation and function of Foxp3(+) effector regulatory T cells.
Cretney E; Kallies A; Nutt SL
Trends Immunol; 2013 Feb; 34(2):74-80. PubMed ID: 23219401
[TBL] [Abstract][Full Text] [Related]
33. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.
Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG
Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells.
Gao Y; Lin F; Su J; Gao Z; Li Y; Yang J; Deng Z; Liu B; Tsun A; Li B
Genes Immun; 2012 Jan; 13(1):1-13. PubMed ID: 22048454
[TBL] [Abstract][Full Text] [Related]
35. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV).
Wongyanin P; Buranapraditkun S; Chokeshai-Usaha K; Thanawonguwech R; Suradhat S
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):170-82. PubMed ID: 19709757
[TBL] [Abstract][Full Text] [Related]
36. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
Ohkura N; Hamaguchi M; Sakaguchi S
Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells and autoimmunity.
Vila J; Isaacs JD; Anderson AE
Curr Opin Hematol; 2009 Jul; 16(4):274-9. PubMed ID: 19417650
[TBL] [Abstract][Full Text] [Related]
38. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.
Weiss EM; Schmidt A; Vobis D; Garbi N; Lahl K; Mayer CT; Sparwasser T; Ludwig A; Suri-Payer E; Oberle N; Krammer PH
J Immunol; 2011 Aug; 187(4):1684-91. PubMed ID: 21746966
[TBL] [Abstract][Full Text] [Related]
39. [From Ipex to foxp3: a new contribution of pediatrics to the understanding of the immune system].
Marabelle A; Meyer M; Demeocq F; Lachaux A
Arch Pediatr; 2008 Jan; 15(1):55-63. PubMed ID: 18155891
[TBL] [Abstract][Full Text] [Related]
40. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
Beyer M; Schultze JL
Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
